KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Exelixis (EXEL) EBT Margin (2016 - 2026)

Exelixis has reported EBT Margin over the past 17 years, most recently at 42.21% for Q1 2026.

  • Quarterly results put EBT Margin at 42.21% for Q1 2026, up 961.0% from a year ago — trailing twelve months through Jan 2026 was 40.57% (up 914.0% YoY), and the annual figure for FY2026 was 40.57%, up 914.0%.
  • EBT Margin for Q1 2026 was 42.21% at Exelixis, roughly flat from 42.23% in the prior quarter.
  • Over the last five years, EBT Margin for EXEL hit a ceiling of 45.96% in Q2 2024 and a floor of 7.41% in Q4 2022.
  • Median EBT Margin over the past 5 years was 23.15% (2022), compared with a mean of 24.8%.
  • Peak annual rise in EBT Margin hit 2890bps in 2023, while the deepest fall reached -2112bps in 2023.
  • Exelixis' EBT Margin stood at 7.41% in 2022, then soared by 390bps to 21.48% in 2023, then soared by 34bps to 28.68% in 2024, then surged by 47bps to 42.23% in 2025, then fell by 0bps to 42.21% in 2026.
  • The last three reported values for EBT Margin were 42.21% (Q1 2026), 42.23% (Q4 2025), and 40.55% (Q3 2025) per Business Quant data.